The Clinicians’ Guide to Managing Immune-Related Adverse Events: An Interactive Algorithm Tool

This multifaceted program which includes a text module and an interactive algorithm tool equips clinicians with guideline-driven recommendations to inform their evaluation and management of immune-related adverse events resulting from checkpoint inhibition.

Share

Program Content

Activities

Pneumonitis and Hypophysitis
My Experiences Managing Pneumonitis and Hypophysitis in Patients Receiving Checkpoint Inhibitor Therapy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 26, 2016

Expires: September 25, 2017

Immune-Related Hepatic and Neurologic AEs
My Experiences Managing Immune-Related Hepatic and Neurologic Adverse Events in Patients Receiving Checkpoint Inhibitor Therapy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 27, 2016

Expires: October 26, 2017

ICIs and Autoimmune Disease
My Experiences Administering Checkpoint Inhibitor Therapy in Patients With Preexisting Autoimmune Disease
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 08, 2017

Expires: February 07, 2018

Faculty

cover img faculity

Michael Postow, MD

Chief, Melanoma Service
Associate Attending Physician
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Osama E. Rahma, MD

Member of the Faculty of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Merck Oncology